Name: Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps (Video) | JoVE Journal
Uploaded: 2019-07-30T15:00:00.000+00:00
Duration: 7 min 17 s
Description: Learn to accurately assess mitochondrial membrane potential in hematopoietic stem and progenitor cells using TMRM with Verapamil to inhibit efflux pumps. This protocol improves measurement reliability for stem cell research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

The authors thank all members of the Ito laboratory, especially K Ito and H Sato, and the Einstein Stem Cell Institute for comments and the Einstein Flow Cytometry and Analytical Imaging core facilities (funded by National Cancer Institute grant P30 CA013330) for help carrying out the experiments. K.I. is supported by grants from the National Institutes of Health (R01DK98263, R01DK115577, and R01DK100689) and the New York State Department of Health as Core Director of Einstein Single-Cell Genomics/Epigenomics (C029154). K.I. Ito is a Research Scholar of the Leukemia and Lymphoma Society.

All methods described here have been approved by the Institutional Animal Care and Use Committee (IACUC) of the Albert Einstein College of Medicine.
1. Preparation of Solutions
<ol>
	<li>Staining Buffer (phosphate-buffered saline (PBS) + 2% fetal bovine serum (FBS)): Add 10 mL of FBS in 500 mL of a sterile PBS solution. 
	NOTE: This solution can be stored at 4 &#176;C for at least one month in sterile condition. Before starting the following procedures, put an aliquot of this solution (50 mL) on ice.</li>
	<li>ACK (ammonium-chloride-potassium) lysing buffer: Place an aliquot of ACK lysing buffer (1 mL) on ice before starting the procedure. 
	NOTE: To prepare the same non-commercial buffer, dissolve 8.02 g of NH4Cl, 1 g of KHCO3 and 37.2 mg of Na2EDTA in 1 L of H2O. Adjust the pH to 7.2-7.4. Store for up to 6 months at room temperature.</li>
	<li>Culture medium: Add 50 ng/mL stem cell factor (SCF) and 50 ng/mL thrombopoietin (TPO) to serum-free medium for culture and expansion of hematopoietic cells (see Table of Material for commercial medium recommended).</li>
	<li>TMRM stock solution: Prepare TMRM (1 &#956;M) solution by dissolving 5 &#956;g of TMRM powder in 10 mL of ethanol. Store this solution at -20 &#176;C protected from the light.</li>
	<li>Verapamil stock solution: Prepare Verapamil (50 mM) solution by diluting 24 mg of Verapamil in 1 mL of ethanol. Store this solution at -20 &#176;C.</li>
	<li>FCCP stock solution: Prepare carbonilcyanide p-triflouromethoxyphenylhydrazone (FCCP) (1 M) solution by dissolving 254 mg in 1 mL of ethanol. Store this solution at -20 &#176;C protected from the light.</li>
</ol>
2. Bone Marrow Isolation
<ol>
	<li>Euthanize the mouse by CO2 inhalation following institutional guidelines and spray the mice with 70% ethanol. 
	NOTE: This step prevents contamination of the cells of interest without compromising experimental results.</li>
	<li>Using a pair of forceps and sharp scissors, make a small snip in the ventral skin of the mouse and stretch the skin.</li>
	<li>Extract the femur and tibia while taking care not to dislodge the heads of the femur as they contain a large amount of bone marrow cells. Place the removed bones in a 6-well plate filled with 1.5 mL of staining buffer. 
	NOTE: This procedure does not require sterile area.</li>
	<li>Remove the muscles from the bones and cut the ends of the bones allowing the exit of the bone marrow (Figure 1A). Place the cleaned bones in new wells with 1.5 mL of staining buffer. 
	NOTE: Muscles and other tissues must be carefully removed to avoid syringe clogging in the next step.</li>
	<li>Flush out the bone marrow using a 3 mL syringe with a 25 G needle. 
	NOTE: Continue to flush the bone marrow until the bone becomes white (Figure 1B).</li>
	<li>Collect all cells in a 1.5 mL tube, centrifuge for 5 min at 180 x g then discard the supernatant (Figure 1C).</li>
	<li>Resuspend the pellet in 300 &#956;L of ice cold ACK lysing buffer very carefully, put on ice for 1 min and immediately inactive lysis by adding 1 mL of staining buffer. Centrifuge for 5 min at 180 x g. 
	NOTE: The cells pellet appears white (Figure 1D). The total number of cells isolated is about 2-4 x 107.</li>
	<li>Resuspend the pellets in 1 mL of staining buffer and filter using a cell-strainer cap (12 x 75 mm2, 5 mL of capacity) with a 35 &#956;m nylon mesh incorporated to obtain mononuclear cells. After blocking, keep the sample on ice.</li>
</ol>
3. Immunostaining for Detection of HSC
<ol>
	<li>Prepare Lineage (Lin) cocktail. In 400 &#956;L of staining buffer, add 4 &#956;L of the following biotinilated antibodies against CD3e, CD4, CD8, B220, CD11b, Gr1, Ter119, CD19, Nk1.1, IgM and Il7Ra to obtain a final dilution 1:100.</li>
	<li>Prepare fluorophores conjugated-antibodies (Abs). In 400 &#956;L of staining buffer, add 4 &#956;L of the following Abs to obtain a final dilution 1:100. Streptavidin-Pacific Blue, Sca1-PE/Cy7, c-kit-APC/Cy7, CD48-APC, CD150-PerCP/Cy5.5 and CD34-FITC. Keep in ice, protected from light.</li>
	<li>Centrifuge the sample for 5 min at 180 x g, then discard the supernatant.</li>
	<li>Add 400 &#956;L of Lin cocktail solution to the cells pellet. Add 4 &#956;L of CD135-biotinilated Ab. Vortex quickly to mix and incubate for 30 min in ice.</li>
	<li>Wash the sample adding 3 mL of staining buffer, spin down for 5 min at 180 x g and discard the supernatant.</li>
	<li>Add 400 &#956;L of Abs solution. Vortex quickly to mix and incubate for 30 min on ice.</li>
	<li>Wash the samples with 3 mL of staining buffer, spin down for 5 min at 180 x g and discard the supernatant.</li>
</ol>
4. TMRM Staining
<ol>
	<li>Prepare TMRM staining solution. Add 2.2 &#956;L of TMRM stock solution and 1.1 &#956;L of Verapamil (2 nM and 50 &#956;M as final concentration, respectively) in 1.1 mL of serum-free medium for culture and expansion of hematopoietic cells (see Table of Material for commercial medium recommended) with TPO and SCF. 
	NOTE: This is the most important step of the protocol. Verapamil addition is necessary to block the efflux pumps which are highly expressed in the HSCs and can extrude TMRM.</li>
	<li>Resuspend the bone marrow in 1 mL of TMRM staining solution, vortex quickly and incubate for 1 h at 37 &#176;C. 
	NOTE: TMRM staining must not be washed out. PE-dedicated compensation control is also resuspended in 100 &#956;L of TMRM staining solution, and subjected to incubation for 1 h at 37 &#176;C after quick vortex.</li>
	<li>Filter the sample using a cell-strainer cap (12 x 75 mm2, 5 mL of capacity) with a 35 &#956;m nylon mesh incorporated to avoid clogging of the flow cytometer. 
	NOTE: TMRM staining increases the possibility of clog formation in the sample. Filtration of the sample just before flow assays is recommended.</li>
	<li>Add 1 &#956;L of 4&#8217;,6-diamidino-2-phenylindole (DAPI) to exclude dead cells by flow cytometry.</li>
</ol>
5. Acquisition by Flow Cytometer
<ol>
	<li>Run bone marrow sample and acquire at least 1 x 106 events.</li>
	<li>Set up the gating strategy to identify the different hematopoietic populations (Figure 2).
	<ol>
		<li>Display live bone marrow mono-nuclear cells (BM-MNCs), DAPI&#8722; fraction, in plot for Pacific Blue to identify CD135&#8722;Lin&#8722; (Lin&#8722;) and Lin+ fractions.</li>
		<li>Plot Lin&#8722; fraction for APC/Cy7 (c-kit) versus PE/Cy7 (Sca-1) to identify multipotent progenitors (MPP) fraction, as c-kit+ and Sca-1+.</li>
		<li>Plot MPP fraction for APC (CD48) versus PerCP/Cy5.5 (CD150) to identify HSC fraction, as CD150+ and CD48&#8722;.</li>
		<li>Display HSC fraction for FITC (CD34) to divide CD34&#8722;-HSC and CD34+-HSC.</li>
	</ol>
	</li>
	<li>Acquire the TMRM intensity (PE channel) in each population.</li>
	<li>After acquisition, add to the sample 1 &#956;L of FCCP to obtain the final concentration of 1 mM and incubate at 37 &#176;C for 5 min, then acquire 1 x 106 events. 
	NOTE: FCCP is a mitochondrial uncoupler which is used to dissipate the &#916;&#936;m. It is used as experimental control to confirm that TMRM staining works correctly. After the administration of FCCP, the TMRM intensity should drastically be decreased (Figure 3A).</li>
	<li>Analyze data normalizing the average intensity of PE of each population by the intensity of PE of all BM-MNCs.</li>
</ol>

<ol><li>Weissman, I. L., Anderson, D. J., Gage, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Stem+and+progenitor+cells%3A+origins%2C+phenotypes%2C+lineage+commitments%2C+and+transdifferentiations%5BTitle%5D)+AND+%22Annual+Review+of+Cell+and+Developmental+Biology%22%5BJournal%5D)">Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations.</a> Annual Review of Cell and Developmental Biology. 17, 387-403 (2001).</li>
<li>Morrison, S. J., Shah, N. M., Anderson, D. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Regulatory+mechanisms+in+stem+cell+biology%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Regulatory mechanisms in stem cell biology.</a> Cell. 88 (3), 287-298 (1997).</li>
<li>Wilson, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hematopoietic+stem+cells+reversibly+switch+from+dormancy+to+self-renewal+during+homeostasis+and+repair%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair.</a> Cell. 135 (6), 1118-1129 (2008).</li>
<li>Morrison, S. J., Scadden, D. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+bone+marrow+niche+for+haematopoietic+stem+cells%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">The bone marrow niche for haematopoietic stem cells.</a> Nature. 505 (7483), 327-334 (2014).</li>
<li>Frenette, P. S., Pinho, S., Lucas, D., Scheiermann, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mesenchymal+stem+cell%3A+keystone+of+the+hematopoietic+stem+cell+niche+and+a+stepping-stone+for+regenerative+medicine%5BTitle%5D)+AND+%22Annual+Review+of+Immunology%22%5BJournal%5D)">Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine.</a> Annual Review of Immunology. 31, 285-316 (2013).</li>
<li>Ito, K., Bonora, M., Ito, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Metabolism+as+master+of+hematopoietic+stem+cell+fate%5BTitle%5D)+AND+%22International+Journal+of+Hematology%22%5BJournal%5D)">Metabolism as master of hematopoietic stem cell fate.</a> International Journal of Hematology. 109 (1), 18-27 (2019).</li>
<li>Ito, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Self-renewal+of+a+purified+Tie2%2B+hematopoietic+stem+cell+population+relies+on+mitochondrial+clearance%5BTitle%5D)+AND+%22Science%22%5BJournal%5D)">Self-renewal of a purified Tie2+ hematopoietic stem cell population relies on mitochondrial clearance.</a> Science. 354 (6316), 1156-1160 (2016).</li>
<li>Bonora, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((ATP+synthesis+and+storage%5BTitle%5D)+AND+%22Purinergic+Signal%22%5BJournal%5D)">ATP synthesis and storage.</a> Purinergic Signal. 8 (3), 343-357 (2012).</li>
<li>Walker, J. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+regulation+of+catalysis+in+ATP+synthase%5BTitle%5D)+AND+%22Current+Opinion+in+Structural+Biology%22%5BJournal%5D)">The regulation of catalysis in ATP synthase.</a> Current Opinion in Structural Biology. 4 (6), 912-918 (1994).</li>
<li>Scaduto, R. C., Grotyohann, L. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Measurement+of+mitochondrial+membrane+potential+using+fluorescent+rhodamine+derivatives%5BTitle%5D)+AND+%22Biophysical+Journal%22%5BJournal%5D)">Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives.</a> Biophysical Journal. 76, 469-477 (1999).</li>
<li>Bonora, M., Ito, K., Morganti, C., Pinton, P., Ito, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Membrane-potential+compensation+reveals+mitochondrial+volume+expansion+during+HSC+commitment%5BTitle%5D)+AND+%22Experimental+Hematology%22%5BJournal%5D)">Membrane-potential compensation reveals mitochondrial volume expansion during HSC commitment.</a> Experimental Hematology. 68, 30-37 (2018).</li>
<li>Goodell, M. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Dye+efflux+studies+suggest+that+hematopoietic+stem+cells+expressing+low+or+undetectable+levels+of+CD34+antigen+exist+in+multiple+species%5BTitle%5D)+AND+%22Nature+Medicine%22%5BJournal%5D)">Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species.</a> Nature Medicine. 3 (12), 1337-1345 (1997).</li>
<li>Spangrude, G. J., Johnson, G. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Resting+and+activated+subsets+of+mouse+multipotent+hematopoietic+stem+cells%5BTitle%5D)+AND+%22Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America%22%5BJournal%5D)">Resting and activated subsets of mouse multipotent hematopoietic stem cells.</a> Proceedings of the National Academy of Sciences of the United States of America. 87 (19), 7433-7437 (1990).</li>
<li>Scharenberg, C. W., Harkey, M. A., Torok-Storb, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+ABCG2+transporter+is+an+efficient+Hoechst+33342+efflux+pump+and+is+preferentially+expressed+by+immature+human+hematopoietic+progenitors%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors.</a> Blood. 99 (2), 507-512 (2002).</li>
<li>Zhou, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+ABC+transporter+Bcrp1%2FABCG2+is+expressed+in+a+wide+variety+of+stem+cells+and+is+a+molecular+determinant+of+the+side-population+phenotype%5BTitle%5D)+AND+%22Nature+Medicine%22%5BJournal%5D)">The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype.</a> Nature Medicine. 7 (9), 1028-1034 (2001).</li>
<li>Simsek, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+distinct+metabolic+profile+of+hematopoietic+stem+cells+reflects+their+location+in+a+hypoxic+niche%5BTitle%5D)+AND+%22Cell+Stem+Cell%22%5BJournal%5D)">The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche.</a> Cell Stem Cell. 7 (3), 380-390 (2010).</li>
<li>Vannini, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Specification+of+haematopoietic+stem+cell+fate+via+modulation+of+mitochondrial+activity%5BTitle%5D)+AND+%22Nature+Communications%22%5BJournal%5D)">Specification of haematopoietic stem cell fate via modulation of mitochondrial activity.</a> Nature Communications. 7, 13125(2016).</li>
<li>Xiao, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hematopoietic+stem+cells+lacking+Ott1+display+aspects+associated+with+aging+and+are+unable+to+maintain+quiescence+during+proliferative+stress%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">Hematopoietic stem cells lacking Ott1 display aspects associated with aging and are unable to maintain quiescence during proliferative stress.</a> Blood. 119 (21), 4898-4907 (2012).</li>
<li>de Almeida, M. J., Luchsinger, L. L., Corrigan, D. J., Williams, L. J., Snoeck, H. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Dye-Independent+Methods+Reveal+Elevated+Mitochondrial+Mass+in+Hematopoietic+Stem+Cells%5BTitle%5D)+AND+%22Cell+Stem+Cell%22%5BJournal%5D)">Dye-Independent Methods Reveal Elevated Mitochondrial Mass in Hematopoietic Stem Cells.</a> Cell Stem Cell. 21 (6), 725-729 (2017).</li>
<li>Hall, A. M., Rhodes, G. J., Sandoval, R. M., Corridon, P. R., Molitoris, B. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In+vivo+multiphoton+imaging+of+mitochondrial+structure+and+function+during+acute+kidney+injury%5BTitle%5D)+AND+%22Kidney+International%22%5BJournal%5D)">In vivo multiphoton imaging of mitochondrial structure and function during acute kidney injury.</a> Kidney International. 83 (1), 72-83 (2013).</li>
<li>Oguro, H., Ding, L., Morrison, S. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((SLAM+family+markers+resolve+functionally+distinct+subpopulations+of+hematopoietic+stem+cells+and+multipotent+progenitors%5BTitle%5D)+AND+%22Cell+Stem+Cell%22%5BJournal%5D)">SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors.</a> Cell Stem Cell. 13 (1), 102-116 (2013).</li>
<li>Nicolli, A., Basso, E., Petronilli, V., Wenger, R. M., Bernardi, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Interactions+of+cyclophilin+with+the+mitochondrial+inner+membrane+and+regulation+of+the+permeability+transition+pore%2C+and+cyclosporin+A-sensitive+channel%5BTitle%5D)+AND+%22The+Journal+of+Biological+Chemistry%22%5BJournal%5D)">Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel.</a> The Journal of Biological Chemistry. 271 (4), 2185-2192 (1996).</li>
<li>Vannini, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+NAD-Booster+Nicotinamide+Riboside+Potently+Stimulates+Hematopoiesis+through+Increased+Mitochondrial+Clearance%5BTitle%5D)+AND+%22Cell+Stem+Cell%22%5BJournal%5D)">The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial Clearance.</a> Cell Stem Cell. 24 (3), 405-418 (2019).</li>
</ol>

The authors have nothing to disclose.

Mitochondrial membrane potential measurement is a cornerstone of the analysis and assessment of mitochondria, which are critical to the metabolic state of the cell. Here, we describe a protocol for the analysis of &#916;&#936;m by TMRM staining. TMRM is a cell-permeant fluorescent dye which accumulates in active mitochondria due to &#916;&#936;m, and its respective levels remain in equilibrium between the extracellular, cytoplasmic and mitochondrial compartments10. This protocol can be adapted for...

Hematopoietic stem cells (HSCs) are self-renewing, multi-potent, and capable of giving rise to all the cells of the blood1,2. Cellular metabolism is a key regulator of HSC maintenance, along with transcriptional factors, intrinsic signals and the microenvironment3,4,5. The proper control of mitochondrial function and quality is therefore critical to HSC maintenance6,7.
Mitochondrial membrane potential (&#916;&#936;m) is a key parameter in the assessment of mitochondria as it directly reflects their functionality, which derives from the equilibrium of proton pumping activity in the electron transport chain and the proton flow through F1/FO ATP synthase. These are both required (depending on gene expression and substrate availability) for the oxygen-dependent phosphorylation of ADP to ATP8,9. Taking advantage of the electronegativity of the mitochondrial compartment, various potentiometric dyes have been developed to measure &#916;&#936;m. One of them is tetramethylrhodamine methyl ester perchlorate (TMRM), which has been extensively used to measure &#916;&#936;m by flow cytometry in a variety of cells10, including hematopoietic stem and progenitor cells11. &#160;
Mitochondrial dyes must be used with some caution in HSCs, however, because the high activity of the xenobiotic efflux pumps of these cells can result in dye extrusion12. Indeed, the extrusion of mitochondrial dyes such as Rhodamine 123 has allowed researchers to isolate HSCs13 or identify HSC &#8220;side populations&#8221; by exploiting the differential extrusion of the dyes Hoechst Blue and Hoechst Red14,15. It has also been shown that Fumitremorgin C, a specific blocker of the ATP-binding cassette sub-family G member 2 (ABCG2) transporter, does not affect the staining pattern of MitoTracker in HSPCs16. After the publication of these results, multiple studies were performed using mitochondrial dyes in the absence of xenobiotic efflux pump inhibitors, leading to the widespread impression that HSCs have only a small number of mitochondria with low &#916;&#936;m16,17,18.
Recently, it was demonstrated, however, that Verapamil, a wide spectrum inhibitor of efflux pumps, significantly modifies the staining pattern of the mitochondrial dye MitoTracker Green19. This discrepancy is likely due to the fact that Fumitremorgin C is highly selective for Abcg2, while HSCs also express other transporters such as Abcb1a (which is only weakly sensitive to Fumitremorgin C)19. We have also reported that other mitochondrial dyes, such as TMRM, Nonyl acridine orange, and Mitotracker Orange (MTO) exhibit the same patterns as Mitotracker Green. More importantly, we have observed that the flow cytometric patterns of HSPCs reflect their &#916;&#936;m in addition to mitochondrial mass11.
The intake of TMRM dye strictly depends on the negative charge of mitochondria, but the resulting accumulation of dye is in constant balance between its intake and clearance by efflux pumps20. The difference in xenobiotic efflux pump expression between HSCs and mature cell populations affects this balance and can lead to biased results. The use of dedicated inhibitors such as Verapamil should be considered in the analysis of &#916;&#936;m by potentiometric dyes. Here we describe a modified protocol for accurate &#916;&#936;m measurement by TMRM-based flow cytometry which corrects for xenobiotic transporter activity through the use of dedicated inhibitors.

<table><tbody><tr><td>ACK lysing buffer</td><td>Life Technologies</td><td>A1049201</td><td></td></tr><tr><td>B220-biotin</td><td>BD Bioscience</td><td>553086</td><td></td></tr><tr><td>CD3e-biotin</td><td>Life Technologies</td><td>13-0031-85</td><td></td></tr><tr><td>CD4-biotin</td><td>Fischer Scientific</td><td>BDB553782</td><td></td></tr><tr><td>CD8-biotin</td><td>Life Technologies</td><td>13-0081-85</td><td></td></tr><tr><td>CD11b-biotin</td><td>BD Bioscience</td><td>553309</td><td></td></tr><tr><td>CD19-biotin</td><td>BD Bioscience</td><td>553784</td><td></td></tr><tr><td>CD34-FITC</td><td>eBioscience</td><td>11-0341-85</td><td></td></tr><tr><td>CD48-APC</td><td>eBioscience</td><td>17-0481-82</td><td></td></tr><tr><td>CD135-biotin</td><td>eBioscience</td><td>13-1351-82</td><td></td></tr><tr><td>CD150-PerCP/Cy5.5&amp;nbsp;</td><td>Biolegend</td><td>115922</td><td></td></tr><tr><td>c-kit-APC/Cy7</td><td>Biolegend</td><td>105826</td><td></td></tr><tr><td>Cyclosporin H</td><td>Millipore Sigma</td><td>SML1575-1MG</td><td></td></tr><tr><td>DAPI solution (1 mg/mL)</td><td>Life Technologies</td><td>62248</td><td></td></tr><tr><td>Fetal Bovine Serum (FBS)</td><td>Denville</td><td>FB5001-H</td><td></td></tr><tr><td>FCCP</td><td>Millipore Sigma</td><td>C2920-10MG</td><td></td></tr><tr><td>Gr1-biotin</td><td>Biolegend</td><td>108404</td><td></td></tr><tr><td>IgM-biotin</td><td>Life Technologies</td><td>13-5790-85</td><td></td></tr><tr><td>Il7R&amp;alpha;-biotin</td><td>eBioscience</td><td>13-1271-85</td><td></td></tr><tr><td>Nk1.1-biotin</td><td>Fischer Scientific</td><td>BDB553163</td><td></td></tr><tr><td>Phosphate buffered saline (PBS)</td><td>Life Technologies</td><td>10010023</td><td></td></tr><tr><td>Sca-1-PE/Cy7</td><td>eBioscience</td><td>25-5981-81</td><td></td></tr><tr><td>SCF murine</td><td>PEPROTECH</td><td>250-03-10UG</td><td></td></tr><tr><td>StemSpan SFEM medium</td><td>STEMCELL technologies</td><td>9605</td><td></td></tr><tr><td>Streptavidin-Pacific Blue</td><td>eBioscience</td><td>48-4317-82</td><td></td></tr><tr><td>Ter119-biotin</td><td>Fischer Scientific</td><td>BDB553672</td><td></td></tr><tr><td>TMRM</td><td>Millipore Sigma</td><td>T5428-25MG</td><td></td></tr><tr><td>TPO</td><td>PEPROTECH</td><td>315-14-10UG</td><td></td></tr><tr><td>Verapamil hydrochloride</td><td>Millipore Sigma</td><td>V4629-1G</td><td></td></tr></tbody></table>

improving the accuracy of flow cytometric assessment of mitochondrial membrane potential in hematopoietic stem and progenitor cells through the inhibition of efflux pumps

Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps

As cellular metabolism is a key regulator of hematopoietic stem cell (HSC) self-renewal, the various roles played by the mitochondria in hematopoietic homeostasis have been extensively studied by HSC researchers. Mitochondrial activity levels are reflected in their membrane potentials (&#916;&#936;m), which can be measured by cell-permeant cationic dyes such as TMRM (tetramethylrhodamine, methyl ester). The ability of efflux pumps to extrude these dyes from cells can limit their usefulness, however. The resulting measurement bias is particularly critical when assessing HSCs, as xenobiotic transporters exhibit higher levels of expression and activity in HSCs than in differentiated cells. Here, we describe a protocol utilizing Verapamil, an efflux pump inhibitor, to accurately measure &#916;&#936;m across multiple bone marrow populations. The resulting inhibition of pump activity is shown to increase TMRM intensity in hematopoietic stem and progenitor cells (HSPCs), while leaving it relatively unchanged in mature fractions. This highlights the close attention to dye-efflux activity that is required when &#916;&#936;m-dependent dyes are used, and as written and visualized, this protocol can be used to accurately compare either different populations within the bone marrow, or the same population across different experimental models.

The protocol described above enables the easy isolation of BM-MNCs from a mouse model. Figure 1 summarizes the main steps of the protocol: bone isolation, flushing out of the bone marrow, red blood cell lysis, and antibody staining followed by TMRM staining to measure mitochondrial membrane potential in a specific hematopoietic population.
BM-MNCs contain several cell populations, including HSCs. The antibody cocktails used in this protocol are well-established in...

Xenobiotic efflux pumps are highly active in hematopoietic stem and progenitor cells (HSPCs) and cause extrusion of TMRM, a mitochondrial membrane potential fluorescent dye. Here, we present a protocol to accurately measure mitochondrial membrane potential in HSPCs by TMRM in the presence of Verapamil, an efflux pump inhibitor.

As cellular metabolism is a key regulator of hematopoietic stem cell (HSC) self-renewal, the various roles played by the mitochondria in hematopoietic ...

improving-accuracy-flow-cytometric-assessment-mitochondrial-membrane

Research

JoVE Journal

Biology

Here, we present a protocol that uses JC-1 dye to assess the mitochondrial membrane potential of cells after being exposed to hypoxia/reoxygenation with or without a protective agent.

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation

We describe a method for using multiparameter flow cytometry to detect mitochondrial reactive oxygen species (ROS) in murine healthy hematopoietic stem and progenitor cells (HSPCs) and leukemia cells from a mouse model of acute myeloid leukemia (AML) driven by MLL-AF9.

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Hematopoietic stem progenitor cells (HSPCs) transition from a quiescent state to a differentiation state due to their metabolic plasticity during blood formation. Here, we present an optimized method for measuring mitochondrial respiration and glycolysis of HSPCs.

Analysis of Hematopoietic Stem Progenitor Cell Metabolism

Here we describe a reliable method to measure mitochondrial mass and membrane potential in ex vivo cultured hematopoietic stem cells and T cells.

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

Metabolic adaptation is fundamental for T cells as it dictates differentiation, persistence, and cytotoxicity. Here, an optimized protocol for monitoring mitochondrial respiration in ex vivo cytokine-differentiated human primary T cells is presented.

Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells

The method presented here summarizes optimized protocols for assessing cellular bioenergetics in non-adherent mouse hematopoietic stem and primitive progenitor cells (HSPCs) using the extracellular flux analyzer to measure the extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) of HSPCs in real time.

Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer

This study reports a novel approach to measure multiple mitochondrial functional parameters based on flow cytometry and double staining with two fluorescent reporters or antibodies to detect changes in mitochondrial volume, mitochondrial membrane potential, reactive oxygen species level, mitochondrial respiratory chain composition, and mitochondrial DNA.

Flow Cytometric Analysis of Multiple Mitochondrial Parameters in Human Induced Pluripotent Stem Cells and Their Neural and Glial Derivatives

Here, we describe a simple protocol for the isolation and staining of murine bone marrow cells to phenotype hemopoietic stem and progenitor cells along with the supporting niche endothelial and mesenchymal stem cells. A method to enrich cells located in endosteal and central bone marrow areas is also included.

Flow Cytometry Analysis of Murine Bone Marrow Hematopoietic Stem and Progenitor Cells and Stromal Niche Cells

This technique describes an effective workflow to visualize and quantitatively measure mitochondrial membrane potential and superoxide levels within HeLa cells using fluorescence-based live imaging.

Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells

Methods for studying mitochondrial bioenergetics under physiologically relevant substrate concentrations in immune cells are limited. We provide a detailed protocol that uses high-resolution fluorespirometry to assess changes in the response of the mitochondrial membrane potential to energy demand in human T-cells, monocytes, and peripheral mononuclear cells.

High-Resolution Fluorespirometry to Assess Dynamic Changes in Mitochondrial Membrane Potential in Human Immune Cells

Learn to accurately assess mitochondrial membrane potential in hematopoietic stem and progenitor cells using TMRM with Verapamil to inhibit efflux pumps. This protocol improves measurement reliability for stem cell research.

Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps (Video) | JoVE Journal

Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps

Explore More Videos